Ranbaxy falls; suspends shipments from two plants
MUMBAI (Reuters) - Shares of Ranbaxy Laboratories(RANB.NS) fell as much as 2.7 percent after the drug maker said on Tuesday it has suspended shipments of pharmaceutical ingredients produced at its Toansa and Dewas plants.
"This voluntary decision was taken as a precautionary measure and out of abundant caution to better allow the company to assess and review the processes and controls. The company will resume shipments after reassuring them about the processes and controls at these facilities," Ranbaxy said in an exchange filing.
Ranbaxy shares were trading up 0.7 percent at 11.46 a.m.
(Reporting by Abhishek Vishnoi; Editing by Subhranshu Sahu)
- Tweet this
- Share this
- Digg this
- Hong Kong protests approach potential National Day flashpoint
- UPDATE 2-U.S. charges four with stealing $100 mln in software, data
- Kurds seize Iraq/Syria border post; Sunni tribe joins fight against Islamic State
- Amal Alamuddin earns high-fashion accolades as Clooney's bride
- Obama, Modi work to deepen improving U.S.-India ties
U.S. President Barack Obama and Indian Prime Minister Narendra Modi agreed on Tuesday to deepen U.S.-Indian cooperation on maritime security to ensure freedom of navigation in what amounts to a response to China's naval muscle-flexing in Asia. Story | Full Coverage
China final HSBC PMI steady in September on stronger global demand but risks remain Full Article